Sexual function with localized prostate cancer: Active surveillance vs radical therapy

BJU International

Volumn 110, Issue 7, 2012, Pages 1032-1039

  Van Den Bergh, Roderick C N ^a   Korfage, Ida J ^a   Roobol, Monique J ^a   Bangma, Chris H ^a   De Koning, Harry J ^a   Steyerberg, Ewout W ^a   Essink Bot, Marie Louise ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

active surveillance; prostate cancer; quality of life; radiation therapy; radical prostatectomy; sexual function

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ERECTILE DYSFUNCTION; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL FUNCTION; COMPARATIVE STUDY; LIBIDO; PATHOPHYSIOLOGY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); WATCHFUL WAITING;

ERECTILE DYSFUNCTION; HUMANS; LIBIDO; MALE; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEXUAL BEHAVIOR; WATCHFUL WAITING;

EID: 84871687433     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10846.x     Document Type: Article

References (26)

1. Boyle P, Ferlay J,. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-8
2. Catalona WJ, Smith DS, Ratliff TL, et al,. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-61
3. Jemal A, Siegel R, Ward E, et al,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
4. Etzioni R, Penson DF, Legler JM, et al,. Overdiagnosis due to prostate specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94: 981-90
5. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Caroll PR,. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004; 22: 2141-9
6. Sanda MG, Dunn RL, Michalski J, et al,. Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med 2008; 38: 1250-61
7. Korfage IJ, Essink-Bot ML, Borsboom GJ, et al,. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005; 116: 291-6
8. van den Bergh RCN, Roemeling S, Roobol MJ, et al,. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009; 55: 1-8
9. Bratt O,. Watching the face of Janus-Active surveillance as a strategy to reduce overtreatment for localised prostate cancer. Eur Urol 2006; 50: 410-2
10. Hayes JH, Ollendorf DA, Pearson SD, et al,. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA 2010; 304: 2373-80
11. van den Bergh RCN, Vasarainen H, van der Poel HG, et al,. Short-term outcomes of the prospective multicenter PRIAS study (Prostate Cancer Research International: Active Surveillance). BJU Int 2010; 105: 956-62
12. Schröder FH, Hugosson J, Roobol MJ, et al,. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8
13. Korfage IJ, Essink-Bot ML, Madalinska JB, et al,. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Qual Life Res 2003; 12: 459-64
14. Korfage IJ, Roobol M, de Koning HJ, Kirkels WJ, Schröder FH, Essink-Bot ML,. Does 'normal' aging imply urinary, bowel, and erectile dysfunction? A general population survey. Urology 2008; 72: 3-9
15. Slob AK, Blom JH, van der Werff te Bosch JJ,. Erection problems in medical practice: differential diagnosis with relatively simple method. J Urol 1990; 143: 46-50
16. Ware J Jr, Kosinski M, Keller SD,. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33
17. Roberts RE, Vernon SW,. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am J Psychiatry 1983; 140: 41-6
18. Marteau TM, Bekker H,. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992; 31: 301-6
19. Choo R, Klotz L, Danjoux C, et al,. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002; 167: 1664-9
20. Soloway MS, Soloway CT, Williams S, et al,. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 2008; 101: 165-9
21. Korfage IJ, De Koning HJ, Essink-Bot ML,. Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study. Qual Life Res 2007; 16: 1627-34
22. Roobol MJ, Schröder FH, van Leenders GL, et al,. Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥100). Eur Urol 2010; 58: 593-9
23. Roobol MJ, Steyerberg EW, Kranse R, et al,. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010; 57: 79-85
24. Thong MS, Mols F, Kil PJ, et al,. Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden. BJU Int 2010; 105: 652-8
25. Van den Bergh RCN, Essink-Bot ML, Roobol MJ, et al,. Anxiety and distress during active surveillance for early prostate cancer. Cancer 2009; 115: 3668-78
26. Fujita K, Landis P, McNeil BK, Pavlovich CP,. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol 2009; 182: 2664-9